Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Effects of Ubiquinol (Reduced Coenzyme Q10) for Dementia: Additional Analysis
jRCT1060240100Active, not recruiting
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of coenzyme q10 in Alzheimer's disease (AD), vascular dementia, dementia with Lewy bodies (DLB) and 2 more, sponsored by none. Started Dec 2024; status: active, not recruiting.
02
Drugs
coenzyme q10
03
Conditions
Alzheimer's disease (AD)vascular dementiadementia with Lewy bodies (DLB)frontotemporal dementia (FTD)Dementia
Beyond the preview
Go deeper on jRCT1060240100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1060240100.